Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation.
Tim A C de VriesRoisin BavaliaGordon ChuHelen XiongKayleigh M van de WielHanne van BallegooijenMenno V HuismanMartin E W HemelsSaskia MiddeldorpJoris R de GrootPublished in: Research and practice in thrombosis and haemostasis (2024)
In the Netherlands, factor Xa inhibitors are increasingly being selected for OAC-naive AF patients. Seven percent of patients switch to a different OAC within 1 year, and the initial DOAC type and dose are strong predictors of switching.